Agent: University Of Iowa Research Foundation20110319483 - 1-adamantyl chalcones for the treatment of proliferative disorders: t20110319482 - Novel treatments: The present invention relates to the treatment of the premonitory symptoms of migraine, to the treatment of aura associated with or without migraine, epilepsy, non-epileptic seizures, stroke or other cardiovascular disorders, to the pre-